Form 4: Fulgent Genetics President and COO Sells Shares to Cover Tax Obligations

Jian Xie, President and COO of Fulgent Genetics, sold 1,594 shares of common stock on September 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On September 3, 2024, Jian Xie, the President and COO of Fulgent Genetics, sold 1,594 shares of the company's common stock.
• The sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on February 28, 2022.
• The shares were sold at prices ranging from $21.815 to $22.10, with a weighted-average sale price of $21.961.
• Following the transaction, Mr. Xie directly owns 341,170 shares of Fulgent Genetics common stock.
• Mr. Xie also indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust, dated January 27, 2010, for which he serves on the investment committee.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction to cover tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine Form 4 filing related to insider stock transactions, specifically the sale of shares to cover tax obligations. Such filings are common and provide transparency into the trading activities of company executives.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates